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Despite the advances in chemotherapy made during the first  part of this century, 
trypanosomes and their insect  vector, the tsetse fly, continue to pose a  serious threat 
to the health and economic well-being of millions of Africans (1). Recent advances in 
the  elucidation  of trypanosomal  metabolism  have  encouraged  the  development  of 
new  chemotherapeutic  agents  specifically  designed  to  exploit  known  biochemical 
differences between  trypanosomes and  their  mammalian  hosts.  Reports  that  trypa- 
nosomes  lack catalase  (2),  a  deficiency thought  to be  secondary to defective  heme 
biosynthesis (3), focused attention on hydrogen peroxide (H~O2) and the regulation of 
its  intracellular  concentration.  Measurements  in  bloodstream  forms of Trypanosoma 
brucei brucei demonstrated an intracellular  H202 concentration of about  70/~M  (4), a 
value  at  least  100-fold  higher  than  that  reported  in  mammalian  cells  (5,  6).  The 
present  and previous (4,  7, 8)  studies suggest that this unusually high concentration 
of H202 and the absence of at least one important enzyme of H202 catabolism  (i.e., 
catalase) constitute a therapeutically exploitable difference in trypanosome biochem- 
istry. We have used buthionine sulfoximine  (BSO), a  potent and specific inhibitor of 
glutathione  biosynthesis  (9),  to  deplete  trypanosomes  of glutathione,  an  important 
component of the cellular  defense  mechanism  against  both  H202  and  free radicals 
(10).  Although the administration  of buthionine sulfoximine to mammalian  cells or 
whole animals  is without apparent  toxic effect, it was anticipated  that  bloodstream 
forms of T.  b. brucei would suffer substantial oxidative and free radical damage when 
depleted of intracellular glutathione. 
Materials  and Methods 
Animals.  Female Swiss Webster mice,  18-24 g, were obtained  from Taconic Farms, Ger- 
mantown, N. Y. 
Organisms.  T.b.  brucei (EATRO 110) were obtained from Dr. W. Trager (The Rockefeller 
University) and stored as stabilates at -80°C in 10% glycerol. Thawed organisms were routinely 
passaged in rodents before use. Intraperitoneal injection of 1 ×  10  '~ motile organisms into mice 
resulted in high parasitemia within 3-4 d with organisms of uniformly slender morphology. 
Isolation of Trypanosomes.  Trypanosomes were isolated from blood according to the procedure 
of Lanham and Godfrey (11) 3-4 d after infection. Infected mice were bled by axillary incision 
with  heparinized  pipettes  under  ether  anesthesia.  Whole  blood  (1-2  ml)  was applied  to a 
column of DE-52 cellulose  (Whatman Inc., Clifton, N. J.) and eluted with phosphate-buffered 
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saline (3:7)  and glucose (PSG). Isolated organisms were washed twice with PSG by centrifu- 
gation. 
ot-Buthionine-SR-Sulfoximine  (BSO).  BSO was prepared by a modification of the published 
procedure (9). Plasma levels of BSO in mice after intraperitoneal  administration were deter- 
mined by amino acid analysis as previously described (12). 
Measurement of Total Intracellular Glutathione (GSH).  GSH was measured by a modification of 
the method of Tietze  (13). Isolated trypanosomes (5-10 X  108) were suspended in  1 ml PSG 
containing 5 mM HCI. Each cell suspension was divided in two and a known amount of GSH 
(Sigma Chemical Co., St. Louis, Mo.) was added to one half to act as an internal standard. The 
preparation  of acid-soluble extracts  of trypanosome lysates using sulfosalicylic acid  (Sigma 
Chemical Co.) at 2.8%, as well as the measurement of GSH content, was performed on both the 
sample and the sample plus standard in parallel.  Extracts were stored at -80°C and assayed 
within  1 wk.  Protein concentration was determined  by the method of Bradford  (14),  using 
bovine serum albumin as standard. 
Assessment of Trypanocidal Activity In Vivo.  Groups of six mice were infected with T. b. brucei by 
intraperitoneal  injection of 1 ×  105 organisms in 0.5  ml  minimal  essential  medium  (Grand 
Island Biological  Co., Grand Island, N. Y.).  10 h after infection, injections of BSO (4 mmol/kg) 
were begun. BSO was administered  intraperitoneally at a concentration of 200 mM every 1.5 
h. At the time treatment was begun, parasitemia was confirmed in each animal by microscopic 
examination  of blood smears obtained  by tail  snip  and  stained  with  Diff-Quik Solution  II 
(Harleco, Gibbstown, N. J.). Mice surviving 40 d were considered cured. 
Results 
Effect  of  BSO  Administration  on  the  T~ypanosomal  GSH  Levels  of  Parasitemic 
Mice.  Because  BSO  is  a  reversible  inhibitor  of GSH  biosynthesis,  successful  long- 
term inhibition in bloodstream forms of T. b. brucei requires the continual presence of 
a  substantial  plasma  BSO  concentration.  Preliminary  experiments  indicated  that 
intraperitoneal  injection of mice with 4  mmol/kg of BSO produced plasma levels of 
inhibitor that reached 5-6 mM in  15-20 min and then declined to about  1 mM at  1.5 
h  after injection.  Based on these findings, a  protocol was adopted in which 4 mmol/ 
kg  of BSO  was  administered  intraperitoneally  every  1.5  h.  Control  experiments 
indicated  that  this  procedure  produced  no overt  toxicity  in  uninfected  mice,  even 
when continued for 18-27 h  (a total administration  of 48-72 mmol/kg of BSO). 
To assess  the effect  of BSO on trypanosomal GSH  levels,  parasitemic  mice were 
given BSO, and bloodstream forms of T.b. brucei were subsequently isolated at various 
times and assayed for GSH. The results are given in Fig.  1. It is evident that the GSH 
level of trypanosomes falls to ~50% of its normal value after 5 h  of exposure to BSO 
and that the rate of decline decreases progressively thereafter.  Trypanosomes isolated 
from infected  animals  after  10 or more h  of BSO treatment  lysed spontaneously at 
25°C and could not be accurately assayed for GSH. 
Effect of BSO Administration on  T~ypanosome Survival in Parasitemic  Mice.  The marked 
instability of isolated trypanosomes containing <~ 1 nmoi GSH/mg protein suggested 
that continued inhibition of GSH biosynthesis might be lethal to the parasites in vivo. 
When mice with very high parasitemias  were given BSO for  18 h  (4 mmol/kg every 
1.5 h)  and then examined,  blood samples were found to be free of parasites.  Despite 
the  absence of parasites,  the  treated  mice were  hypothermic,  exhibited  ruffled  fur, 
and  generally  appeared  more  ill  than  untreated  parasitemic  controls.  The  treated 
mice died  within  3  d  while  still  apparently  free of parasites;  untreated  parasitemic 
controls died  1-2 d  later. 
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FIG.  1.  Level of GSH  in T. b,  brucei  after administration of BSO to parasitemic mice. Parasitemic 
mice (3-4 d after infection with 1-2 × 10  5 organisms) were injected intraperitoneally with 4 mmol/ 
kg BSO at time zero and at  1.5-h intervals thereafter. At the times indicated, trypanosomes were 
isolated from the blood and analyzed for GSH as described in Materials and Methods. The values 
reported represent GSH equivalents (i.e., GSH + 2 × GSSG); previous studies indicated that GSSG 
represents <5% of GSH (8). 
TABLE  I 
Effect of BSO on the Survival of 712. b. brucei-infected Mice 
Number of injections*  Survival time:~ 
0  4,4,5,5,5,5 
6  4,4,4,5,5,5 
12  5,5,5,5,8,9 
18  11, 11, 12, 16, C, C§ 
* 4 mmoi/kg every 1.5 h. Mice were parasitemic at the onset of treatment with 1-5 ×  103 
parasites/ml blood. 
Days to death after infection. Deaths were associated with high parasitemia (0.5-5  × 
l09 parasites/ml blood within 24 h of death). 
§ C, cured (survived 40 d without detectable parasitemia). 
experiment was therefore carried out using mice with lower initial parasitemias. These 
mice were divided into groups that received 4 mmol/kg BSO intraperitoneally  every 
1.5  h  for a  total  of 0,  6,  12,  or  18  injections.  The  survival  times  of the  individual 
animals  are  given in Table  I. Of the  mice receiving  18 injections,  two were cured. 
Four others  had significantly prolonged survival,  but  eventually  died  with  marked 
parasitemias.  In a similar experiment in which animals received 0, 4, or 12 injections 
(data  not  shown),  two  of the  four  animals  in  the  most  extensively  treated  group 
showed a  clearing of parasitemia and significantly prolonged survival  (15 and  16 d); 
however, these animals eventually succumbed to trypanosomiasis. 
Discussion 
The  formation  of H20~  by  cells  appears  to  be  an  unavoidable  consequence  of 
aerobic metabolism.  The steady-state intracellular  concentration of H202 represents 
a  balance between rates of production, catabolism,  and diffusion out of the cell  (6). 
Thus,  because  bloodstream  forms of T.  b.  brucei  lack catalase  (2)  and  are  without 
detectable GSH peroxidase activity  (8),  H202 accumulates to a  concentration of 70 
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Earlier  work  in  this  laboratory  concerned  with  the  development  of therapeutic 
agents  exploitive  of increased  trypanosomal  H.~O.~ has  identified  a  class  of active 
compounds  that  promote  homolytic  cleavage  of  H~O2  into  the  highly  reactive 
hydroxyl and hydroperoxy radicals (4,  7). Consistent with the role of GSH in cellular 
defense against free radical damage, it has been proposed that decreased GSH levels 
sensitize trypanosomes to these agents (8). However, the interpretation of experiments 
in which GSH is depleted  with chemically reactive compounds, such as dianaide or 
arsenicals, is complicated by questions of reagent specificity (15,  16). 
An  alternative  approach  to GSH  depletion  is  possible with  BSO,  a  potent  and 
specific inhibitor of ),-glutamylcysteine synthetase, the  first enzyme of GSH biosyn- 
thesis (9). Studies with mice and rats have shown that inhibition of GSH biosynthesis 
is followed by a  depletion of intracellular GSH by the continuing reactions of GSH 
utilization,  including  translocation of intact GSH out of cells.  In tissues that  have a 
naturally high  rate of GSH turnover, the depletion  of GSH after inhibition  of new 
synthesis can be rapid and dramatic; kidney and liver GSH levels can be reduced by 
>80'~,  in  less than  2  h,  for example. In other tissues  (e.g., erythrocytes, heart,  lung, 
and spleen), GSH turnover is intrinsically slow, and temporary inhibition of synthesis 
does not produce a  marked depletion  (12). 
In the present studies,  BSO was administered to parasitemic mice, and  the GSH 
content  of the  trypanosomes isolated  from the  blood was shown  to decline  50'Y, in 
about 5 h. Because the trypanosomes divide with a generation time of 7-9 h (data not 
shown), much of the observed depletion of GSH is probably attributable to dilution 
of preexisting GSH into an increasingly large cytoplasmic volume. It should be noted, 
however, that the unknown effect of GSH depletion on the generation time and cell 
volume of T.  b.  brucei precludes a  firm conclusion as to the mechanism by which  the 
GSH concentration drops after inhibition of biosynthesis. 
Trypanosomes depleted  of >75%  of their  initial  GSH content  were  found  to  be 
extremely fragile when  isolated  and  examined  in  vitro.  A  similar parasite  fragility 
apparently also develops in the parasitemic mouse given BSO. In all cases examined, 
T.  b.  brucei  could  not  be  identified  in  blood  samples collected  16-18  h  after BSO 
administration was begun. As shown in Table I, it was possible in some cases to cure 
the infection if plasma BSO concentrations were maintained for about 27 h. In other 
cases,  mice apparently  rendered  aparasitemic  by  BSO  were  found  to  relapse after 
several days.  It is probable in these cases that  a  small number of parasites survived 
the  initial  treatment  and  then  multiplied  after  BSO  had  been  cleared  from  the 
plasma. It is notable in this regard that, in contrast to diamide or the arsenicals, BSO 
does not  react  directly with  GSH.  For BSO  to cause GSH depletion,  the  parasites 
must  either lose GSH  through  some natural  metabolic process or they must  divide 
and thereby dilute the GSH pool. Metabolically quiescent trypanosomes are therefore 
expected to be resistant  to BSO-induced  lysis. It is also possible that, in some cases, 
surviving trypanosomes were initially sequestered at sites within  the central  nervous 
system and were not exposed to a sufficiently high concentration of BSO. Amino acid 
analysis of the tissues of mice given BSO shows that the concentrations of inhibitor in 
the brain are substantially lower than those found in other tissues (12). Recrudescence 
of trypanosomiasis from the central nervous system after chemotherapy has recently 
been demonstrated  (17). 
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therapeutic use of the compound in larger animals.  The present  results nevertheless 
indicate a means by which a biochemical difference between mammals and T. b. brucei 
may be therapeutically exploited.  Thus, BSO is a  drug with no known mammalian 
toxicity and with little intrinsic chemical reactivity. It apparently acts solely to inhibit 
GSH biosynthesis and thus does not directly affect other cellular thiois. At present,  T. 
b.  brucei is the only organism known to be damaged by BSO-induced GSH depletion, 
a  susceptibility  attributable  to  the  protozoan's  limited  ability  to  deal  with  self- 
generated  H~O~. It  is apparent  that  practical therapies  should be possible with  the 
development  of more  tightly  bound  inhibitors  of GSH  biosynthesis  and  with  the 
concurrent administration of compounds such as hematoporphyrin that intensify even 
further the increased endogenous oxidative stress  to which T.  b.  brucei is exposed. It is 
further  noted  that  other  pathogenic organisms are  also  catalase  deficient  (e.g.,  T. 
cruzi)  (18,  19) and may be susceptible to similar therapies. 
Summary 
With the expectation that trypanosomal glutathione (GSH) plays a major protective 
role against the endogenous oxidant stress  that results from high intracellular levels of 
H20~, we sought to deplete  Trypanosoma  brucei brucei of their GSH through inhibition 
of its  biosynthesis.  Administration  of buthionine  sulfoximine  (BSO),  a  reversible 
inhibitor of y-glutamylcysteine synthetase, to parasitemic mice resulted in a  progres- 
sive decrease in trypanosome GSH content, such that  parasites  isolated after 5 h  of 
BSO  treatment  contained  50%  of normal  values.  When  BSO  administration  was 
continued for 18 h  (intraperitoneal  injection of 4 mmol/kg every 1.5 h), parasitemias 
temporarily  cleared.  When  inhibitory  plasma  levels  of BSO  were  maintained  for 
about  27  h,  two out of six  infected  mice were cured and  the  rest  had  significantly 
prolonged survival. These findings demonstrate the potential value of GSH depletion 
for the treatment of trypanosomiasis. 
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